Study Suggests New Treatment Target for Deadly Brain Tumors
A study by UT Southwestern Medical Center researchers published online today in Nature reveals new insight into why the most common, deadly kind of brain tumor in adults recurs and identifies a potential target for future therapies.
Glioblastoma multiforme (GBM) currently is considered incurable. Despite responding to initial therapy, the cancer almost always returns. GBM is a fast-growing, malignant brain tumor that occurred in 15 percent of the estimated 22,000 Americans diagnosed with brain and nervous system tumors in 2010. The median survival rate is about 15 months, according to the National Cancer Institute.
“We identified a subset of brain tumor cells that are slower growing or remain at rest, and appear to be the source of cancer recurrence after standard therapy in which the drug temozolomide is given to stop the tumor’s growth,” said Dr. Luis Parada, chairman of developmental biology and director of the Kent Waldrep Center for Basic Research on Nerve Growth and Regeneration. “Current therapy targets fast-growing tumor cells but not those responsible for new tumors. To the best of our knowledge, this is the first identification of a cancer stem-like cell in a spontaneously forming tumor inside a mammal.”
White arrows point to a subset of tumor cells that express green fluorescent protein (GFP) but rarely stain for Ki67, a marker of proliferation. This indicates that the tumor cells that appear green are in a resting state. Image is altered from an original image courtesy of Nature.
Using a genetically engineered mouse model of GBM, the researchers found that the resting tumor cells act more like stem cells – the non-cancerous cells the body uses to repair and replenish itself – which exist in a resting state until needed, he explained.
The existence of cancer stem cells in solid tumors remains controversial, Dr. Parada said, with some scientists in the field taking the concept for granted and others rejecting it outright. In addition, the definition of a cancer stem cell is a moving target, hence the use of the term stem-like cell in this study, he said.
“We are trying to better understand these cells. The important point is that we now are faced with technical obstacles, not conceptual ones,” said Dr. Parada.
Notes about this brain cancer research
Other UT Southwestern researchers involved include lead author and former postdoctoral student of developmental biology Dr. Jian Chen, who is now a senior scientist at OriGene Technologies in Wuxi, China; Yanjiao Li, a research associate of developmental biology; Dr. Tzong-Schiue Yu, a former graduate student of developmental biology and pediatrics; Dr. Renée M. McKay, assistant professor of developmental biology; Dr. Dennis K. Burns, professor of pathology; and Dr. Steven G. Kernie, a former associate professor of pediatrics and developmental biology. Drs. Kernie and Yu are now at Columbia University Medical Center.
Funding: The study was supported by grants from the National Institutes of Health, the Cancer Prevention and Research Institute of Texas, the Goldhirsh Foundation, and the James S. McDonnell Foundation.
Contact: Deborah Wormser – The University of Texas Southwestern Medical Center
Source: The University of Texas Southwestern Medical Center press release
Image Source: Neuroscience image adapted from press release image and provided courtesy of Nature
Original Research: Abstract for “A restricted cell population propagates glioblastoma growth after chemotherapy” by Jian Chen, Yanjiao Li, Tzong-Shiue Yu, Renée M. McKay, Dennis K. Burns, Steven G. Kernie and Luis F. Parada in Nature online 1 August 2012 doi:10.1038/nature11287
By Neuroscience News
Neuroscience News posts news from various labs, universities, hospitals and news departments around the world. Related Articles
19 Responses to Study Suggests New Treatment Target for Deadly Brain Tumors
You must be logged in to post a comment Login
The Brain from Top to Bottom Blog – Beginner Level » Proteins That Guide the Wiring of the Brain:
Study Suggests New Treatment Target for Deadly Brain Tumors #neuroscience http://t.co/20kuoffS
Study Suggests New Treatment Target for Deadly Brain Tumors #neuroscience http://t.co/20kuoffS
Study Suggests New Treatment Target for Deadly Brain Tumors #neuroscience http://t.co/20kuoffS
Study Suggests New Treatment Target for Deadly #BrainTumors http://t.co/IC2yUNqx via @neurosciencenew
RT @neurosciencenew: Study Suggests New Treatment Target for Deadly Brain Tumors #neuroscience http://t.co/Yv4EVJ5V
RT @neurosciencenew: Study Suggests New Treatment Target for Deadly Brain Tumors #neuroscience http://t.co/Yv4EVJ5V
Study Suggests New Treatment Target for Deadly Brain Tumors http://t.co/iR5xntFp
Study Suggests New Treatment Target for Deadly Brain Tumors http://t.co/q6YQgjKf
Study Suggests New Treatment Target for Deadly Brain Tumors http://t.co/hI9QsfyR via @zite
Study Suggests New Treatment Target for Deadly Brain Tumors #neuroscience http://t.co/20kuoffS
Study Suggests New Treatment Target for Deadly Brain Tumors: A study by UT Southwestern Medical Center researche… http://t.co/tRZVmXBd
Study Suggests New Treatment Target for Deadly Brain Tumors: A study by UT Southwestern Medical Center researche… http://t.co/tRZVmXBd
Study Suggests New Treatment Target for Deadly Brain Tumors: A study by UT Southwestern Medical Center researche… http://t.co/tRZVmXBd
#Medical News http://t.co/OJphyIb3
Why deadly tumors recur. "@NeuroscienceNew: Study Suggests New Treatment Target for Deadly Brain Tumors #neuroscience http://t.co/dc4dYoh5"
#Medical News Neuroscience News wrote a new blog post: Study Suggests New Treatment Target … http://t.co/981Cj2xK http://t.co/3sLYXqAX
Study Suggests New Treatment Target for Deadly Brain Tumors: A study by UT Southwestern Medical Center researche… http://t.co/tRZVmXBd
<3 @meidesign: RT @stevens1
Study Suggests New Treatment Target for #BrainTumors http://t.co/i58kmAva via @neurosciencenew
Study Suggests New Treatment Target for Deadly Brain Tumors: A study by UT Southwestern Medical Center researche… http://t.co/tRZVmXBd